The role of loss of Y chromosome in prostate cancer progression and survivorship
Description: The Y chromosome is one of two sex chromosomes in humans, and is present only in males. As men age, some cells may lose their Y chromosome, and this loss seems to affect a range of diseases and other aspects of health. There is a compelling yet underexplored hypothesis that loss of the Y chromosome (LOY) may increase the risk of developing prostate cancer and influence its progression. Our project explores LOY and its impact on prostate cancer, which affects millions of men worldwide and is a leading cause of cancer-related deaths.
In our research, we will study large populations of men to explore the presence of LOY in both blood and prostate tissue samples. We aim to uncover how LOY affects the development and progression of prostate cancer. Additionally, we will examine whether healthy lifestyles, like quitting smoking or adopting a healthier diet, can slow cancer progression with or without the presence of LOY, suggesting lifestyle choices could potentially offset genetic risks.
Our goal is to reduce the impact of prostate cancer on men's health worldwide. By elucidating the relationship between LOY and prostate cancer, we hope to lay the foundation for better early detection methods and personalized treatment approaches, significantly enhancing survival rates and quality of life for men. These findings could inform public health guidelines, advocating for lifestyle modifications to improve cancer survival.
Funder: American Cancer Society
Amount: $217,500
Funding type: award
Start date: 2025-01-01
End date: 2027-12-31
Investigator: Anqi Wang (lead)
Institutions: Harvard University, President and Fellows of Harvard College, Harvard T. H. Chan School of Public Health
Subfield: Cancer Research
Domain: Life Sciences
Funded outputs count: 0
Funder award ID: PF-24-1299583-01-CTPS
OpenAlex ID: G4731412830
